Supreme Court Tort Ruling Deals Set Back to Industry

The Supreme Court ruled last week that FDA approval does not shield drug companies from personal injury suits, a decision that will have major implications for personal injury lawsuits in a wide range of industries, attorneys say. The 6-3 decision in Wyeth v. Levine also sets an important precedent for legal disputes that center on federal preemption of state laws, and it could give a green light to many state personal injury suits, attorneys say. At the heart of the dispute is whether FDA labeling requirements prohibit personal injury lawsuits in state courts...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers